National Coverage Analysis (NCA) for Ocular Photodynamic Therapy (OPT) with Verteporfin for Macular Degeneration (CAG-00066R4)
Select the ’Print Complete Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.
To print an entire document, including all codes in all code groups, use the 'Need a PDF' button or the 'Print Complete Record' button.
To print only the current visible page contents, use the 'Print' button in the page header.
Fourth reconsideration for Ocular Photodynamic Therapy (OPT) with Verteporfin for Macular Degeneration (this document)